Collaborative systems are required to combat the rising challenge of antimicrobial resistance in health care facilities and the community
These germs of disease have taken toll of humanity since the beginning of things—taken toll of our prehuman ancestors since life began here. But by virtue of this natural selection of our kind we have developed resisting power; to no germs do we succumb without a struggle …
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug‐resistant infections. Report to the Secretary‐General of the United Nations. April 2019. https://www.who.int/antimicrobial-resistance/interagency-coordination-group/final-report/en/ (viewed May 2019).
- 2. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic‐resistant bacteria and tuberculosis. Lancet Inf Dis 2018; 18: 318–327.
- 3. Australian Commission on Safety and Quality in Health Care. CARAlert data update 10 – 1 November 2018 to 31 December 2018. Sydney: ACSQHC, 2019. https://www.safetyandquality.gov.au/publications/caralert-data-update-10-1-november-to-31-december-2018/ (viewed Apr 2019).
- 4. Kwong JC, Lane CR, Romanes F, et al. Translating genomics into practice for real‐time surveillance and response to carbapenemase‐producing Enterobacteriaceae: evidence from a complex multi‐institutional KPC outbreak. PeerJ 2018; 6: e4210.
- 5. Roberts LW, Harris PN, Ben Zakour NL, et al. Genomic investigation of an outbreak of carbapenemase‐producing Enterobacter cloacae: long‐read sequencing reveals the context of blaIMP4 on a widely distributed IncHI2 plasmid. BioRxiv 2017; https://doi.org/10.1101/172536.
- 6. Eyre DW, Sheppard AE, Madder H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018; 379: 1322–1331.
- 7. Jeffery‐Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev 2018; 31: e00029–17.
- 8. Heath CH, Dyer JR, Pang S, et al. Candida auris sternal osteomyelitis in a man from Kenya visiting Australia, 2015. Emerg Infect Dis 2019; 25: 192–194.
- 9. World Health Organization. Disease outbreak news: Typhoid fever – Islamic Republic of Pakistan. https://www.who.int/csr/don/27-december-2018-typhoid-pakistan/en/ (viewed Apr 2019).
- 10. Qamar FN, Yousafzai MT, Khalid M, et al. Outbreak investigation of ceftriaxone‐resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case–control study. Lancet Infect Dis 2018; 18: 1368–1376.
- 11. Klemm EJ, Shakoor S, Page AJ, et al. Emergence of an extensively drug‐resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third‐generation cephalosporins. mBio 2018; 9: e00105–18.
- 12. Jennison AV, Whiley D, Lahra MM, et al. Genetic relatedness of ceftriaxone‐resistant and high‐level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018. Euro Surveil 2019; 24: 1900118.
- 13. Australian Government Department of Health. National Notifiable Diseases Surveillance System. http://www9.health.gov.au/cda/source/cda-index.cfm (viewed Apr 2019).
- 14. Williamson DA, Kirk MD, Sintchenko V, Howden BP. The importance of public health genomics to ensure health security for Australia. Med J Aust 2019; 210: 295–297. https://www.mja.com.au/journal/2019/210/7/importance-public-health-genomics-ensuring-health-security-australia.
- 15. Australian Government Department of Health and Department of Agriculture and Water Resources. Implementation plan: Australia's first National Antimicrobial Resistance Strategy 2015–2019. Canberra: Commonwealth of Australia, 2016. https://www.amr.gov.au/resources/national-amr-implementation-plan (viewed Apr 2019).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Deborah Williamson is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (GNT1123854). Benjamin Howden is supported by an NHMRC Practitioner Fellowship (GNT1105905).
David Patterson has received research grants or honoraria for participation in advisory boards from Shionogi, MSD, Pfizer, Achaogen, Entasis Therapeutics and Accelerate Diagnostics.